Evidence map›Paper›PMID 42194247›Full record

ArticleBioengineering (Basel, Switzerland)2026

Deep-Learning-Based 3D Dose Distribution Prediction for VMAT Lung Cancer Treatment Using an Enhanced UNet3D Architecture with Composite Loss Functions.

Philip Chung Yin Mak, Luoyi Kong, Lawrence Wing Chi Chan

Abstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Philip Chung Yin MakDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.ORCID 0000-0002-7610-9569
Luoyi KongDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.ORCID 0000-0002-0049-718X
Lawrence Wing Chi ChanDepartment of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong SAR, China.ORCID 0000-0001-6451-2273

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high complexity of radiation therapy for lung cancer necessitates effective planning of advanced treatments such as Volumetric Modulated Arc Therapy (VMAT) by radiation oncologists. The current VMAT treatment planning process typically involves extensive manual interaction and a time-consuming, trial-and-error, iterative approach that requires planners' experience. This can lead to varying levels of plan quality. To improve the quality of radiotherapy treatment plans quickly and accurately, this research presents a new architecture, Enhanced UNet3D, to generate three-dimensional (3-D) dose distributions for lung cancer patients. Enhanced UNet3D utilises a symmetric encoder-decoder architecture with residual connections and a target region-attention module to achieve high accuracy in dose shaping within the PTV. A new composite objective function, Enhanced Combined Loss (ECLoss), that includes both SharpLoss, a structure-aware DVH-guided loss, and 3D gradient regularisation, has been developed to address voxel-level class imbalance and achieve realistic spatial dose falloff. This research utilised a retrospective dataset of 170 VMAT plans to train and validate the proposed model. On the test set (

Indexed as

3D U-Netattentioncomposite lossdeep learningdose predictionDVHlung cancerradiotherapy planningVMAT

Identifiers

PMID42194247
PMCPMC13203807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.